CoCrMo LOCK Bipolar Femoral Heads FU
A Post-market Study Evaluating Clinical and Safety Outcomes of Bipolar Hemiarthroplasty Using CoCrMo LOCK Bipolar Femoral Heads in Subjects with Hip Fracture
1 other identifier
observational
60
1 country
1
Brief Summary
Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of CoCrMo LOCK bipolar femoral heads. The eligible study population is represented by the entire population that underwent a hip replacement with CoCrMo LOCK bipolar femoral heads from 1st January 2023 onwards at the site in accordance with the indication for use of the product.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 20, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
March 26, 2025
March 1, 2025
3.2 years
March 11, 2025
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the revision rate of CoCrMo LOCK Bipolar femoral heads at 24 months after surgery.
At 24 months after intraoperative visit
Secondary Outcomes (8)
Evaluation of the dislocation rate (including close reduction) in subjects with CoCrMo LOCK Bipolar femoral heads at 24 months after bipolar hemiarthroplasty
At 24 months after intraoperative visit
Evaluation of the revision incidence of any hip component for any reason at 24 months after bipolar hemiarthroplasty.
At 24 months after intraoperative visit
Evaluation of acetabular erosion (according to Baker classification) in subjects with CoCrMo LOCK Bipolar femoral heads at 12 months after Bipolar Hemiarthroplasty.
At 12 months after intraoperative visit
Assessment of Harris Hip Score (HHS) at 24 months after Bipolar Hemiarthroplasty with CoCrMo LOCK Bipolar femoral heads.
At 24 months after intraoperative visit
Assessment of Oxford Hip Score (OHS) completed by subjects with CoCrMo LOCK Bipolar femoral heads at 24 months after Bipolar Hemiarthroplasty.
At 24 months after intraoperative visit
- +3 more secondary outcomes
Study Arms (1)
CoCrMo LOCK bipolar femoral head implanted patient
Patients who underwent hip arthroplasty with CoCrMo LOCK bipolar femoral heads from 1at January 2023 onwards.
Eligibility Criteria
Patients who underwent partial hip arthroplasty with CoCrMo LOCK bipolar femoral heads from 1st January 2023 onwards
You may qualify if:
- Displaced intracapsular hip fracture (Garden III-IV).
- Subjects underwent a Bipolar Hemiarthroplasty with a CoCrMo LOCK Bipolar femoral head as per their Indication For Use from January 1st, 2023, onwards.
- No concurrent joint disease at the time of the surgery.
- Absence of severe cognitive dysfunction demonstrated by 3 or more correct answers on the Pfeiffer test.
- Ability to ambulate independently with or without walking aids before surgery.
- Subject willingness to participate.
You may not qualify if:
- Undisplaced or minimally displaced intracapsular hip fracture (Garden I-II).
- Any CoCrMo LOCK Bipolar femoral head contraindication for use as reported in the current Instruction For Use.
- Pathological fracture secondary to malignant disease.
- Subjects with rheumatoid arthritis or symptomatic osteoarthritis.
- Previous treatment to the same hip for a fracture at the time of the surgery.
- Subjects who were deemed unsuitable for the surgical procedures by the anesthesiologist.
- Severe cognitive dysfunction or cognitive impairment demonstrated by 2 or less correct answers on the Pfeiffer test.
- Unable to walk before surgery (e.g., wheelchair or bed-ridden subjects).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Splošna bolnišnica Celje
Celje, 3000, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2025
First Posted
March 20, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
March 26, 2025
Record last verified: 2025-03